Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Virtu Financial
VIRT
$5.05B
| $9.91M | ﹤0.01% |
297,563
+126,173
| +74% | +$4.31M |
|
1677
Middleby
MIDD
$5.29B
| $9.91M | ﹤0.01% |
66,662
+8,124
| +14% | +$1.07M |
|
|
CMA
1678
PUT
DELISTED
Comerica
CMA
| $9.9M | ﹤0.01% |
113,900
+87,900
| +338% | +$7.08M |
|
1679
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.68B
| $9.89M | ﹤0.01% |
245,064
+15,797
| +7% | +$650K |
|
1680
Teck Resources
TECK
$31.3B
| $9.87M | ﹤0.01% |
206,144
+133,960
| +186% | +$5.8M |
|
1681
PBF Energy
PBF
$8.81B
| $9.84M | ﹤0.01% |
362,977
+71,591
| +25% | +$2.29M |
|
1682
Acadia Pharmaceuticals
ACAD
$4.89B
| $9.84M | ﹤0.01% |
368,304
-66,682
| -15% | -$1.59M |
|
1683
Northern Oil and Gas
NOG
$2.61B
| $9.83M | ﹤0.01% |
458,022
-221,502
| -33% | -$4.97M |
|
1684
CALL
Repligen
RGEN
$9.45B
| $9.83M | ﹤0.01% |
+60,000
| New | +$9.4M |
|
1685
Axalta
AXTA
$7.93B
| $9.81M | ﹤0.01% |
303,737
-317,672
| -51% | -$9.32M |
|
1686
Adtran
ADTN
$658M
| $9.78M | ﹤0.01% |
1,125,703
+319,364
| +40% | +$2.77M |
|
1687
iShares MSCI Mexico ETF
EWW
$1.87B
| $9.78M | ﹤0.01% |
141,000
-19,037
| -12% | -$1.29M |
|
|
EFOR
1688
Everforth Inc
EFOR
$1.37B
| $9.77M | ﹤0.01% |
202,781
+19,168
| +10% | +$884K |
|
1689
Ally Financial
ALLY
$13.6B
| $9.76M | ﹤0.01% |
215,540
-355,180
| -62% | -$14.6M |
|
1690
Eagle Materials
EXP
$6.41B
| $9.73M | ﹤0.01% |
47,069
-532
| -1% | -$117K |
|
|
MZTI
1691
The Marzetti Company
MZTI
$3.22B
| $9.72M | ﹤0.01% |
59,146
-596
| -1% | -$99.5K |
|
1692
PUT
iShares MSCI South Korea ETF
EWY
$27.6B
| $9.72M | ﹤0.01% |
+100,000
| New | +$9.14M |
|
1693
Maplebear
CART
$11.6B
| $9.72M | ﹤0.01% |
215,993
-9,651
| -4% | -$395K |
|
1694
Sensient Technologies
SXT
$5.53B
| $9.71M | ﹤0.01% |
103,354
-95,305
| -48% | -$8.99M |
|
1695
Brixmor Property Group
BRX
$9.21B
| $9.7M | ﹤0.01% |
369,937
-73,153
| -17% | -$1.93M |
|
1696
Atlantic Union Bankshares
AUB
$6.09B
| $9.7M | ﹤0.01% |
274,675
+58,831
| +27% | +$2.02M |
|
1697
CALL
Amgen
AMGN
$226B
| $9.69M | ﹤0.01% |
29,600
+26,200
| +771% | +$8.31M |
|
|
OKLO
1698
PUT
Oklo
OKLO
$8.64B
| $9.69M | ﹤0.01% |
135,000
+110,000
| +440% | +$12.3M |
|
1699
Badger Meter
BMI
$3.78B
| $9.68M | ﹤0.01% |
55,501
-12,790
| -19% | -$2.3M |
|
1700
Casella Waste Systems
CWST
$5.79B
| $9.68M | ﹤0.01% |
98,821
+8,407
| +9% | +$780K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.